Literature DB >> 4210297

Comparative pharmacokinetics of amikacin and kanamycin.

J T Clarke, R D Libke, C Regamey, W M Kirby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4210297     DOI： 10.1002/cpt1974156610

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  34 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Pharmacological evaluation of amikacin in neonates.

Authors:  J B Howard; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

3.  Hemodialyzer clearances of gentamicin, kanamycin, tobramycin, amikacin, ethambutol, procainamide, and flucytosine, with a technique for planning therapy.

Authors:  T G Christopher; A D Blair; A W Forrey; R E Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

4.  Renal pharmacology of netilmicin.

Authors:  P J Chiu; G H Miller; A D Brown; J F Long; J A Waitz
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

5.  Distribution of gentamicin and amikacin in rabbit tissues.

Authors:  M L Kornguth; C M Kunin
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

6.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

7.  Effects of gestational age, birth weight, and hypoxemia on pharmacokinetics of amikacin in serum of infants.

Authors:  M G Myers; R J Roberts; N J Mirhij
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

8.  Amikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients.

Authors:  M A French; F B Cerra; M E Plaut; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

9.  Amikacin pharmacokinetics in pediatric patients with malignancy.

Authors:  T G Cleary; L K Pickering; W G Kramer; S Culbert; L S Frankel; S Kohl
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

10.  Bronchial secretion levels of amikacin.

Authors:  W L Dull; M R Alexander; J E Kasik
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.